Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Allied-Bristol Life Sciences Launches ieCa Therapeutics From NYU School Of Medicine To Develop Novel Cancer Therapeutics Targeting The Wnt Pathway

 

Allied-Bristol Life Sciences Launches ieCa Therapeutics From NYU School Of Medicine To Develop Novel Cancer Therapeutics Targeting The Wnt Pathway

2016-03-30 07:03:23| drugdiscoveryonline Home Page

Allied-Bristol Life Sciences, LLC (ABLS), a biopharmaceutical enterprise jointly owned between Allied Minds and Bristol-Myers Squibb Company, announced that it has launched a new subsidiary, iβeCa Therapeutics, to license proprietary compounds from NYU School of Medicine that target the Wnt signalling pathway

Tags: the life school develop

Category:Biotechnology and Pharmaceuticals

Latest from this category	All news
»	15.11 TOMIX 98693 183B 15.11 6014 15.11 WBC L 15.11 SHY 15.11 brightMEMORY A1aime 15.11 15.11 JOCHUM JO1 LAPONE 15.11 More »